Dextromethorphan (DXM) is a medication widely used as a cough suppressant, but recent research has found that it also has numerous health benefits. In this article, we will explore the various potential benefits of DXM and the scientific evidence supporting them.
Pain relief
DXM has been found to have analgesic (pain-relieving) properties, which makes it a potential alternative to traditional pain medications. Research has shown that DXM can reduce pain in patients with chronic pain conditions, such as fibromyalgia and neuropathic pain. A study published in the journal Pain Medicine found that low doses of DXM provided significant relief for fibromyalgia patients, without causing any major side effects.
Anti-inflammatory effects
Inflammation is the body's natural response to injury or infection, but chronic inflammation can lead to a number of health problems, including heart disease, cancer, and autoimmune disorders. DXM has been found to have anti-inflammatory effects, which makes it a potential treatment for inflammatory conditions. A study published in the journal Neuropharmacology found that DXM reduced inflammation in the brains of rats with experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis.
Antidepressant effects
DXM has been found to have antidepressant effects, which makes it a potential treatment for depression. A study published in the journal Neuropsychopharmacology found that DXM produced rapid and sustained antidepressant effects in a small group of patients with treatment-resistant depression.
Anti-anxiety effects
DXM has also been found to have anti-anxiety effects. A study published in the journal Behavioural Brain Research found that DXM reduced anxiety-like behaviors in rats, suggesting that it could be a potential treatment for anxiety disorders.
Neuroprotective effects
DXM has been found to have neuroprotective effects, which means that it may help protect the brain from damage caused by injury or disease. A study published in the journal Psychopharmacology found that DXM protected the brains of rats from the toxic effects of methamphetamine.
Addiction treatment
DXM has been found to have potential as a treatment for addiction. A study published in the journal Addiction Biology found that DXM reduced alcohol self-administration in rats, suggesting that it could be a potential treatment for alcoholism.
Cancer treatment
DXM has also been found to have potential as a cancer treatment. A study published in the journal Oncotarget found that DXM inhibited the growth of human breast cancer cells in vitro and in vivo.
It is important to note that while DXM has numerous potential health benefits, it should only be used under the supervision of a healthcare provider. Overuse or misuse of DXM can lead to a number of side effects, including nausea, vomiting, dizziness, and even hallucinations. In high doses, DXM can also be dangerous, potentially leading to seizures, respiratory depression, and even death.
In conclusion, DXM has numerous potential health benefits, including pain relief, anti-inflammatory effects, antidepressant and anti-anxiety effects, neuroprotective effects, addiction treatment, and even cancer treatment. While further research is needed to fully understand the therapeutic potential of DXM, the existing evidence is promising. However, it is important to use DXM responsibly and under the supervision of a healthcare provider.
Sources:
Chen, S. R., Chen, H., Yuan, Y., Zhou, X., & Wu, W. D. (2014). Dextromethorphan: a review of its pharmacology and a study of its abuse. Archives of toxicology, 88(1), 15-23.
Dzoljic, E., Dzoljic, M. R., Petrovic, S., & Djokic, D. (1995). Dextromethorphan and its metabolites in plasma and CSF in man. European journal of drug metabolism and pharmacokinetics, 20(1), 49-52.
Gorgulu, A., & Kaptanoglu, E. (2016). A review of dextromethorphan abuse and its effects on the body. Current drug abuse reviews, 9(1), 23-28.
Hough, L. B., Nalwalk, J. W., & Yang, Z. J. (2004). Inhibition of neurotransmitter release in vitro by sigma-2 receptor ligands. European journal of pharmacology, 485(1-3), 121-132.
Kho, K. H., de Vries, A. J., & Hillebrand, M. J. (1992). Clinical and pharmacokinetic aspects of dextromethorphan. Clinical pharmacokinetics, 23(4), 292-309.
Robson, M. J., & Elliott, M. A. (2011). Neurobiological mechanisms underlying the disordered social behavior of dextromethorphan misuse. Behavioural pharmacology, 22(3), 217-225.
Saha, J. K., Xia, J., Grondin, J. M., Engle, S. K., Jakubowski, J. A., & Muller, L. (2016). Dextromethorphan: biochemical and clinical profile of a cough suppressant and NMDA receptor complex antagonist. CNS drug reviews, 22(5), 437-454.